Literature DB >> 26625822

Fitting Cure Rate Model to Breast Cancer Data of Cancer Research Center.

Ahmad Reza Baghestani1, Farid Zayeri, Mohammad Esmaeil Akbari, Leyla Shojaee, Naghmeh Khadembashi, Parviz Shahmirzalou.   

Abstract

BACKGROUND: The Cox PH model is one of the most significant statistical models in studying survival of patients. But, in the case of patients with long-term survival, it may not be the most appropriate. In such cases, a cure rate model seems more suitable. The purpose of this study was to determine clinical factors associated with cure rate of patients with breast cancer.
MATERIALS AND METHODS: In order to find factors affecting cure rate (response), a non-mixed cure rate model with negative binomial distribution for latent variable was used. Variables selected were recurrence cancer, status for HER2, estrogen receptor (ER) and progesterone receptor (PR), size of tumor, grade of cancer, stage of cancer, type of surgery, age at the diagnosis time and number of removed positive lymph nodes. All analyses were performed using PROC MCMC processes in the SAS 9.2 program.
RESULTS: The mean (SD) age of patients was equal to 48.9 (11.1) months. For these patients, 1, 5 and 10-year survival rates were 95, 79 and 50 percent respectively. All of the mentioned variables were effective in cure fraction. Kaplan-Meier curve showed cure model's use competence.
CONCLUSIONS: Unlike other variables, existence of ER and PR positivity will increase probability of cure in patients. In the present study, Weibull distribution was used for the purpose of analysing survival times. Model fitness with other distributions such as log-N and log-logistic and other distributions for latent variable is recommended.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26625822     DOI: 10.7314/apjcp.2015.16.17.7923

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  3 in total

1.  Long-Term Disease-Free Survival of Non-Metastatic Breast Cancer Patients in Iran: A Survival Model with Competing Risks Taking Cure Fraction and Frailty into Account

Authors:  Vahid Ghavami; Mahmood Mahmoudi; Abbas Rahimi Foroushani; Hossein Baghishani; Fatemeh Homaei Shandiz; Mehdi Yaseri
Journal:  Asian Pac J Cancer Prev       Date:  2017-10-26

2.  Comparison Cure Rate Models by DIC Criteria in Breast Cancer Data

Authors:  Ahmad Reza Baghestani; Parviz Shahmirzalou; Soheila Sayad; Mohammad Esmaeil Akbari; Farid Zayeri
Journal:  Asian Pac J Cancer Prev       Date:  2018-06-25

3.  Survival Rate and Prognostic Factors among Iranian Breast Cancer Patients.

Authors:  Mojtaba Meshkat; Ahmad Reza Baghestani; Farid Zayeri; Maryam Khayamzadeh; Mohammad Esmaeil Akbari
Journal:  Iran J Public Health       Date:  2020-02       Impact factor: 1.429

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.